|
1
|
Vestbo J, Hurd SS, Agusti AG, Jones PW,
Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ,
Nishimura M, et al: Global strategy for the diagnosis, management,
and prevention of chronic obstructive pulmonary disease: GOLD
executive summary. Am J Respir Crit Care Med. 187:347–365. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reynolds HY: Diagnostic and management
strategies for diffuse interstitial lung disease. Chest.
113:192–202. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Khalil N, O'Connor RN, Unruh HW, Warren
PW, Flanders KC, Kemp A, Bereznay OH and Greenberg AH: Increased
production and immunohistochemical localization of transforming
growth factor-beta in idiopathic pulmonary fibrosis. Am J Respir
Cell Mol Biol. 5:155–162. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Postlethwaite AE, Keski-Oja J, Moses HL
and Kang AH: Stimulation of the chemotactic migration of human
fibroblasts by transforming growth factor beta. J Exp Med.
165:251–256. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yanagisawa K, Osada H, Masuda A, Kondo M,
Saito T, Yatabe Y, Takagi K and Takahashi T and Takahashi T:
Induction of apoptosis by Smad3 and down-regulation of Smad3
expression in response to TGF-beta in human normal lung epithelial
cells. Oncogene. 17:1743–1747. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yanagihara K and Tsumuraya M: Transforming
growth factor beta 1 induces apoptotic cell death in cultured human
gastric carcinoma cells. Cancer Res. 52:4042–4045. 1992.PubMed/NCBI
|
|
7
|
Teramoto T, Kiss A and Thorgeirsson SS:
Induction of p53 and Bax during TGF-beta 1 initiated apoptosis in
rat liver epithelial cells. Biochem Biophys Res Commun. 251:56–60.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bai L, Yu Z, Wang C, Qian G and Wang G:
Dual role of TGF-β1 on Fas-induced apoptosis in lung epithelial
cells. Respir Physiol Neurobiol. 177:241–246. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zanetti D, Poli G, Vizio B, Zingaro B,
Chiarpotto E and Biasi F: 4-hydroxynonenal and transforming growth
factor-beta1 expression in colon cancer. Mol Aspects Med.
24:273–280. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Attisano L and Wrana JL: Smads as
transcriptional co-modulators. Curr Opin Cell Biol. 12:235–243.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Massagué J: How cells read TGF-beta
signals. Nat Rev Mol Cell Biol. 1:169–178. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyazono K: TGF-beta/SMAD signaling and
its involvement in tumor progression. Biol Pharm Bull.
23:1125–1130. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ryu JH, Colby TV and Hartman TE:
Idiopathic pulmonary fibrosis: Current concepts. Mayo Clin Proc.
73:1085–1101. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu N, Barbosa AC, Chapman SL,
Bezprozvannaya S, Qi X, Richardson JA, Yanagisawa H and Olson EN:
DNA binding-dependent and -independent functions of the Hand2
transcription factor during mouse embryogenesis. Development.
136:933–942. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu CX, Gong HR, Liu XY, Wang J, Zhao CM,
Huang RT, Xue S and Yang YQ: A novel HAND2 loss-of-function
mutation responsible for tetralogy of Fallot. Int J Mol Med.
37:445–451. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu X and Howard MJ: Transcripts encoding
HAND genes are differentially expressed and regulated by BMP4 and
GDNF in developing avian gut. Gene Expr. 10:279–293. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cipolla E, Fisher AJ, Gu H, Mickler EA,
Agarwal M, Wilke CA, Kim KK, Moore BB and Vittal R: IL-17A
deficiency mitigates bleomycin-induced complement activation during
lung fibrosis. FASEB J. 13:5543–5556. 2017. View Article : Google Scholar
|
|
19
|
Zhang T, Jiang T, Zhang F, Li C, Zhou YA,
Zhu YF and Li XF: Involvement of p21Waf1/Cip1 cleavage during
roscovitine-induced apoptosis in non-small cell lung cancer cells.
Oncol Rep. 23:239–245. 2010.PubMed/NCBI
|
|
20
|
Ii T, Satomi Y, Katoh D, Shimada J, Baba
M, Okuyama T, Nishino H and Kitamura N: Induction of cell cycle
arrest and p21(CIP1/WAF1) expression in human lung cancer cells by
isoliquiritigenin. Cancer Lett. 207:27–35. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schmider-Ross A, Pirsig O, Gottschalk E,
Denkert C, Lichtenegger W and Reles A: Cyclin-dependent kinase
inhibitors CIP1 (p21) and KIP1 (p27) in ovarian cancer. J Cancer
Res Clin Oncol. 132:163–170. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Neto AG, McCutcheon IE, Vang R, Spencer
ML, Zhang W and Fuller GN: Elevated expression of p21 (WAF1/Cip1)
in hormonally active pituitary adenomas. Ann Diagn Pathol. 9:6–10.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hagimoto N, Kuwano K, Inoshima I, Yoshimi
M, Nakamura N, Fujita M, Maeyama T and Hara N: TGF-beta 1 as an
enhancer of Fas-mediated apoptosis of lung epithelial cells. J
Immunol. 168:6470–6478. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Betts-Obregon BS, Mondragon AA, Mendiola
AS, LeBaron RG, Asmis R, Zou T, Gonzalez-Fernandez F and Tsin AT:
TGFβ induces BIGH3 expression and human retinal pericyte apoptosis:
A novel pathway of diabetic retinopathy. Eye (Lond). 30:1639–1647.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Poluha W, Poluha DK, Chang B, Crosbie NE,
Schonhoff CM, Kilpatrick DL and Ross AH: The cyclin-dependent
kinase inhibitor p21 (WAF1) is required for survival of
differentiating neuroblastoma cells. Mol Cell Biol. 16:1335–1341.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gorospe M, Wang X, Guyton KZ and Holbrook
NJ: Protective role of p21(Waf1/Cip1) against prostaglandin
A2-mediated apoptosis of human colorectal carcinoma cells. Mol Cell
Biol. 16:6654–6660. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Suzuki A, Tsutomi Y, Akahane K, Araki T
and Miura M: Resistance to Fas-mediated apoptosis: Activation of
caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene
family ILP. Oncogene. 17:931–939. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suzuki A, Tsutomi Y, Miura M and Akahane
K: Caspase 3 inactivation to suppress Fas-mediated apoptosis:
Identification of binding domain with p21 and ILP and inactivation
machinery by p21. Oncogene. 18:1239–1244. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu Y, Bei Y, Li Y and Chu H: Phenotypic
and functional transformation in smooth muscle cells derived from
varicose veins. J Vasc Surg Venous Lymphat Disord. 5:723–733. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hsieh HL, Wang HH, Wu WB, Chu PJ and Yang
CM: Transforming growth factor-beta1 induces matrix
metalloproteinase-9 and cell migration in astrocytes: Roles of
ROS-dependent ERK- and JNK-NF-kappaB pathways. J Neuroinflammation.
7:882010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu HW, Liu QF and Liu GN: Positive
regulation of the Egr-1/osteopontin positive feedback loop in rat
vascular smooth muscle cells by TGF-beta, ERK, JNK, and p38 MAPK
signaling. Biochem Biophys Res Commun. 396:451–456. 2010.
View Article : Google Scholar : PubMed/NCBI
|
